Potential for antioxidant therapy of cystic fibrosis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Changes in redox state clearly play a role in airway inflammation and mucus rheology. Furthermore CFTR (cystic fibrosis transmembrane conductance regulator), the defective protein in cystic fibrosis (CF), not only is regulated by redox state but also directly modulates the epithelial redox environment through transepithelial flux of glutathione. The purpose of this review is to explore the potential therapeutic interest of antioxidant molecules in CF. RECENT FINDINGS: Several antioxidants have been shown to have mucolytic and anti-inflammatory properties. Some antioxidants such as zinc and vitamin C may also help increase epithelial chloride secretion through CFTR-dependent and independent pathways. Other antioxidants are showing promise in helping CFTR mobilization to plasma membranes. SUMMARY: The many levels of potential application offered by antioxidants make this class of molecules one of the promising areas of therapeutic development for CF. Several redox-modulating agents have a high likelihood of providing useful approaches for the treatment of many aspects of CF airway disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein kinase C signaling and oxidative stress
Gopalakrishna, R., & Jaken, S. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00221-5 · Cited by 701
Venglarik, C. J., Girón-Calle, J., Wigley, A. F., Malle, E., Watanabe, N., & Forman, H. J. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00002.2003 · Cited by 48
Cited by
Jones, D. P. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1865 · Cited by 1,726
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Cantin, A. M., Hartl, D., Konstan, M. W., & Chmiel, J. F. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.03.003 · Cited by 496
Self-citationHigh-dose oral N -acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis
Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., & Herzenberg, L. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511304103 · Cited by 253
Disruption of mitochondrial redox circuitry in oxidative stress
Jones, D. P. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.07.008 · Cited by 176
Quinn, R. A., Lim, Y. W., Maughan, H., Conrad, D., Rohwer, F., & Whiteson, K. L. (2014) · mBio · doi:10.1128/mbio.00956-13 · Cited by 115
“The CF lung environment is known to be high in ROS, due to immune cell activity in response to chronic microbial infection (57, 58) as well as phenazines (59), and antioxidant therapy has been proposed to alleviate pathology (60).”
Background
Metadata
- Authors
- Cantin, A. M.
- Venue
- Current Opinion in Pulmonary Medicine
- Published
- 2004-11
- Volume
- 10
- Issue
- 6
- Pages
- 531-536
- ISSN
- 1070-5287 (ISSN-L)
- OpenAlex
- W2312873060
- Cited by
- 51
- References
- 2
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential for antioxidant therapy of cystic fibrosis. https://app.cochat.ai/papers/10.1097/01.mcp.0000138997.29276.a1
- The paper
- Cantin, A. M. (2004). Potential for antioxidant therapy of cystic fibrosis. Current Opinion in Pulmonary Medicine. https://doi.org/10.1097/01.mcp.0000138997.29276.a1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.